Clinical Trial Update: Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder. [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated aripiprazole as dual therapy in chronic stable schizophrenia or schizoaffective disorder; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED